Skip to main content
. Author manuscript; available in PMC: 2015 May 13.
Published in final edited form as: Calcif Tissue Int. 2014 Dec 6;96(3):256–263. doi: 10.1007/s00223-014-9932-x

Fig. 1.

Fig. 1

Human primary myoblast VDR mRNA fold change. After being treated for 18 h with three concentrations of 1,25(OH)2D3 (1 pmol/L, 10 pmol/L, and 1 nmol/L), fold change of VDR mRNA was significantly increased between control and 1 nmol/L (1.36 ± 0.33) in human primary myoblasts established from three healthy young adults (P = 0.05). Data presented as (mean ± SD) and analyzed via ANOVA and Tukey’s post hoc test. Statistical significance versus control group, *P ≤ 0.05